Imbria Pharmaceuticals Announces Publication of IMPROVE-DiCE Phase 2a Data in Circulation, Demonstrating Ninerafaxstat as a Potential First-in-Class Therapy Targeting Cardiac ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...
The American Journal of Managed Care

Exercise-Induced Hypertension a Risk Factor for Sudden Cardiac Death, Review Finds

The findings show exercise-induced hypertension increases myocardial oxygen demand. A new review suggests exercise-induced hypertension (EIH) is a risk factor for sudden cardiac death (SCD), but that ...